KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) Other Non Operating Income (2016 - 2026)

Novartis Ag's Other Non Operating Income history spans 15 years, with the latest figure at -$50.0 million for Q1 2026.

  • On a quarterly basis, Other Non Operating Income fell 394.12% to -$50.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$203.0 million, a 234.44% decrease, with the full-year FY2025 number at -$136.0 million, down 197.14% from a year prior.
  • Other Non Operating Income hit -$50.0 million in Q1 2026 for Novartis Ag, up from -$92.0 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for NVS hit a ceiling of $104.0 million in Q1 2023 and a floor of -$92.0 million in Q4 2025.
  • Historically, Other Non Operating Income has averaged $12.2 million across 5 years, with a median of $17.0 million in 2025.
  • Biggest five-year swings in Other Non Operating Income: surged 431.25% in 2023 and later plummeted 394.12% in 2026.
  • Tracing NVS's Other Non Operating Income over 5 years: stood at $24.0 million in 2022, then fell by 25.0% to $18.0 million in 2023, then skyrocketed by 83.33% to $33.0 million in 2024, then crashed by 378.79% to -$92.0 million in 2025, then skyrocketed by 45.65% to -$50.0 million in 2026.
  • Business Quant data shows Other Non Operating Income for NVS at -$50.0 million in Q1 2026, -$92.0 million in Q4 2025, and -$20.0 million in Q3 2025.